HealthEquity, Inc. $HQY Shares Sold by Cambiar Investors LLC

Key Points

• Cambiar Investors LLC has significantly reduced its stake in HealthEquity, Inc. by 41.8%, selling nearly 10,000 shares, bringing their holdings to approximately $1.22 million.
• Analysts have raised their price targets for HealthEquity, with JMP Securities setting a target of $117 and Barrington Research increasing it to $125, indicating a strong positive outlook for the stock.
• The company reported earnings per share of $0.97 for the last quarter, surpassing expectations and showing growth from the previous year's $0.80 EPS.

Cambiar Investors LLC decreased its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 41.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,848 shares of the company's stock after selling 9,932 shares during the quarter. Cambiar Investors LLC's holdings in HealthEquity were worth $1,224,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC raised its stake in HealthEquity by 24.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 6,380 shares of the company's stock worth $564,000 after acquiring an additional 1,265 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its stake in HealthEquity by 7,983.6% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 24,655 shares of the company's stock worth $2,179,000 after acquiring an additional 24,350 shares in the last quarter. GAMMA Investing LLC raised its stake in HealthEquity by 25.9% during the 1st quarter. GAMMA Investing LLC now owns 1,571 shares of the company's stock worth $139,000 after acquiring an additional 323 shares in the last quarter. WCM Investment Management LLC acquired a new stake in HealthEquity during the 1st quarter worth $20,230,000. Finally, Oppenheimer Asset Management Inc. raised its stake in HealthEquity by 6.5% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 75,206 shares of the company's stock worth $6,646,000 after acquiring an additional 4,614 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

HealthEquity Price Performance

HQY stock traded down $1.24 on Friday, reaching $89.82. 1,284,430 shares of the company's stock were exchanged, compared to its average volume of 879,297. The stock has a fifty day moving average of $96.78 and a 200-day moving average of $96.64. HealthEquity, Inc. has a twelve month low of $73.84 and a twelve month high of $116.65. The firm has a market cap of $7.77 billion, a PE ratio of 65.56, a P/E/G ratio of 1.41 and a beta of 0.54. The company has a quick ratio of 4.06, a current ratio of 4.06 and a debt-to-equity ratio of 0.50.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.81 by $0.16. The company had revenue of $330.80 million for the quarter, compared to analyst estimates of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%.During the same quarter in the prior year, the company earned $0.80 earnings per share. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. As a group, equities analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

HQY has been the subject of several research analyst reports. Bank of America increased their price objective on HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a report on Wednesday, June 4th. Raymond James Financial reissued a "strong-buy" rating and issued a $120.00 price objective (up from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. The Goldman Sachs Group increased their price objective on HealthEquity from $94.00 to $104.00 and gave the company a "neutral" rating in a report on Wednesday, June 4th. Wall Street Zen raised HealthEquity from a "hold" rating to a "buy" rating in a report on Friday, June 6th. Finally, Royal Bank Of Canada upped their price target on HealthEquity from $112.00 to $117.00 and gave the stock an "outperform" rating in a research note on Wednesday, June 4th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $118.55.

Insider Transactions at HealthEquity

In other news, Director Jon Kessler sold 134,183 shares of the business's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $112.08, for a total value of $15,039,230.64. Following the completion of the transaction, the director directly owned 253,510 shares of the company's stock, valued at $28,413,400.80. The trade was a 34.61% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Michael Henry Fiore sold 1,794 shares of HealthEquity stock in a transaction on Monday, July 7th. The shares were sold at an average price of $101.73, for a total value of $182,503.62. Following the completion of the sale, the executive vice president directly owned 53,225 shares of the company's stock, valued at approximately $5,414,579.25. This represents a 3.26% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 291,744 shares of company stock valued at $32,705,007 over the last three months. 1.50% of the stock is currently owned by insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.